Cardiovascular Health: Key Concepts and Risk Factors

Cardiovascular health describes the functional integrity of the heart, blood vessels, and the circulatory system that sustains oxygen delivery and metabolic exchange throughout the body. This page covers how cardiovascular function is defined clinically, the mechanisms underlying cardiovascular disease, the principal risk factor categories, and the thresholds that distinguish preventive management from acute clinical intervention. It serves as a reference for individuals navigating cardiovascular services, professionals operating within cardiology and primary care settings, and researchers working across the broader landscape of human health.

Definition and scope

Cardiovascular health refers to the sustained capacity of the heart and vascular network to maintain adequate perfusion — the delivery of oxygenated blood to tissues — without pathological obstruction, structural failure, or arrhythmic disruption. The World Health Organization (WHO) classifies cardiovascular diseases (CVDs) as the leading cause of death globally, accounting for an estimated 17.9 million deaths per year (WHO, Cardiovascular Diseases Fact Sheet).

Within the United States, the Centers for Disease Control and Prevention (CDC) reports that heart disease is the number one cause of death, responsible for approximately 1 in 5 deaths annually (CDC, Heart Disease Facts). The scope of cardiovascular health encompasses:

1. Cardiac structure and function — including the myocardium, valves, pericardium, and conduction system
2. Arterial and venous integrity — including large vessels (aorta, pulmonary arteries) and peripheral vasculature
3. Hemodynamic parameters — blood pressure, cardiac output, and vascular resistance
4. Electrophysiological regulation — heart rate, rhythm, and conduction pathways
5. Metabolic interdependence — lipid metabolism, glucose regulation, and inflammatory signaling that directly affect vascular walls

Cardiovascular health intersects with metabolic health, physical activity status, and stress physiology, all of which modulate cardiac and vascular function through distinct biological pathways.

How it works

The cardiovascular system operates as a closed-loop pressure circuit. The heart functions as a dual pump: the right ventricle drives deoxygenated blood to the lungs for gas exchange, while the left ventricle propels oxygenated blood into the systemic circulation. Arterial walls must flex under systolic pressure and recoil during diastole — a property called compliance — that diminishes with age and atherosclerotic disease.

Atherosclerosis is the primary pathological mechanism underlying most cardiovascular events. It develops through endothelial injury, lipid infiltration (particularly low-density lipoprotein, or LDL, cholesterol), inflammatory cell recruitment, and the formation of fibrous plaques within arterial walls. When a plaque ruptures, it triggers acute thrombosis, which can occlude a coronary artery (producing myocardial infarction) or a cerebral artery (producing ischemic stroke).

Modifiable vs. Non-modifiable risk factors represent a central clinical distinction:

This distinction shapes the structure of cardiovascular prevention, as detailed in the American Heart Association (AHA) and American College of Cardiology (ACC) joint guidelines. The Framingham Heart Study, a longitudinal research program operated through the National Heart, Lung, and Blood Institute (NHLBI), produced foundational risk prediction models still embedded in clinical practice, including the 10-year atherosclerotic cardiovascular disease (ASCVD) risk calculator.

For a broader orientation to the biological systems involved, the conceptual overview of how human health works provides structural context across organ systems.

Common scenarios

Cardiovascular conditions present across a spectrum of acuity and chronicity. The most operationally significant clinical scenarios include:

Hypertension (high blood pressure): The CDC estimates that 47% of U.S. adults have hypertension, defined as a sustained blood pressure at or above 130/80 mmHg under the 2017 ACC/AHA guidelines. Hypertension is frequently asymptomatic, making screening through preventive health frameworks critical for early identification.

Coronary artery disease (CAD): CAD arises when atherosclerotic narrowing reduces perfusion to the myocardium. Stable CAD produces exertional angina; unstable CAD presents as acute coronary syndrome (ACS), which constitutes a medical emergency requiring immediate intervention.

Heart failure: A syndrome in which the heart cannot pump sufficient blood to meet metabolic demands. Heart failure with reduced ejection fraction (HFrEF) involves a left ventricular ejection fraction below 40%, while heart failure with preserved ejection fraction (HFpEF) involves normal or near-normal ejection fraction but impaired diastolic filling. These two subtypes differ mechanistically and respond to different pharmacological strategies.

Arrhythmias: Disorders of cardiac electrical conduction, ranging from atrial fibrillation (the most common sustained arrhythmia, affecting an estimated 2.7 to 6.1 million Americans according to the CDC) to life-threatening ventricular tachycardia.

Stroke: Although classified separately as a cerebrovascular event, ischemic stroke shares the same atherosclerotic and cardioembolic mechanisms as coronary disease, linking it directly to cardiovascular risk profiles. Cardiovascular health connects here to brain health and cognitive function through shared vascular pathways.

Decision boundaries

Clinical decision-making in cardiovascular health is structured around defined thresholds that separate watchful monitoring from pharmacological or procedural intervention.

Blood pressure thresholds under the 2017 ACC/AHA guidelines (Whelton et al., JACC 2018) establish four stages:

1. Normal: below 120/80 mmHg
2. Elevated: 120–129 / below 80 mmHg
3. Stage 1 Hypertension: 130–139 / 80–89 mmHg
4. Stage 2 Hypertension: 140 or higher / 90 mmHg or higher

Lipid management thresholds are stratified by ASCVD risk category. The 2018 ACC/AHA Cholesterol Guideline recommends high-intensity statin therapy for patients with a 10-year ASCVD risk of 20% or higher, LDL-C above 190 mg/dL (as in familial hypercholesterolemia), or established atherosclerotic disease.

Ejection fraction cutoffs define heart failure subtype and drug eligibility. An ejection fraction below 35% triggers consideration of implantable cardioverter-defibrillator (ICD) therapy under CMS coverage criteria (CMS National Coverage Determination 20.4).

Procedural intervention thresholds — including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) — are governed by ACC/AHA procedural appropriateness criteria, which weigh anatomical severity (e.g., left main stenosis above 50%), symptom burden, and functional testing results.

Cardiovascular risk does not operate in isolation. The social determinants of health — including housing stability, food access, and neighborhood-level air quality — are documented drivers of cardiovascular outcome disparities across U.S. populations, as outlined in the Healthy People initiative and tracked through U.S. health data and statistics. Cardiovascular outcomes also intersect with chronic disease burden and health equity frameworks that define how access to cardiac services is distributed across demographic and geographic lines.

References

• World Health Organization — Cardiovascular Diseases Fact Sheet
• Centers for Disease Control and Prevention — Heart Disease Facts
• CDC — High Blood Pressure Facts
• CDC — Atrial Fibrillation
• [National Heart, Lung,